Abstract
The newly synthesized compound and putative 5-HT2 antagonist ritanserin, but not the structurally related compound R 56413, resembles pirenperone in that it acts as a pure antagonist in an LSD-saline drug discrimination assay in the rat. Ritanserin exceeded pirenperone in terms of behavioral specificity; the lowest effective dose of ritanserin in antagonizing LSD was one order of magnitude higher than that of pirenperone, but the compound depressed rate of operant responding only at doses that were about 1000-fold higher than those at which pirenperone was effective. Ritanserin exerted effects in an open field test which were reminiscent of anxiolytic drug activity in the rat; its effects were greater than those of pirenperone, R 56413 and the benzodiazepines chlordiazepoxide and diazepam. The results of experiments on antagonism of 5-HT-induced hypothermia and of the 5-HTP-induced headtwitch response fail to support the possibility that the putative anxiolytic effects of ritanserin in the rat can be ascribed simply to a pharmacologically defined action at 5-HT receptors.
Similar content being viewed by others
References
Abramson HA, Jarvik ME, Kaufman MR, Kornetsky C, Levine A, Wagner M (1955) Lysergic acid diethylamide (LSD-25): I. Physiological and perceptual responses. J Psychol 39:3–10
Appel JB, White FJ, Holohean AM (1982) Analyzing mechnism(s) of hallucinogenic drug action with drug discrimination procedures. Neurosci Biobehav Rev 6:529–536
Blumstein LK, Crawley JN (1983) Further characterization of a simple, automated exploratory model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 18:37–40
Bush K, Johnson WC (1950) LSD-25 as an aid in psychotherapy. Dis Nerv System 11:241–253
Cameron OG, Appel JB (1973) A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats. Psychopharmacologia 33:117–134
Carter RB, Leander JD (1980) Evidence for a peripheral effect of serotonin or metabolites in 5-hydroxytryptophan-induced hypothermia. Neuropharmacology 19:777–784
Charney DS, Heniger GR, Redmond DE (1983) Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci 33:19–29
Cohen S (1967) Psychotomimetic agents. Annu Rev Pharmacol 7:301–318
Colpaert FC (1977) Narcotic cue and narcotic state. Life Sci 20:1097–1108
Colpaert FC (1978) Discriminative stimulus properties of narcotic analgesic drugs. Pharmacol Biochem Behav 9:863–887
Colpaert FC (1984a) Drug discrimination: behavioral, pharmacological, and molecular mechanisms of discriminative drug effects. In: Goldberg SR, Stolerman IP (eds) Behavioral analysis of drug dependence, Academic Press New York (in press)
Colpaert FC (1984b) Cross generalization with LSD and yohimbine in the rat. Eur J Pharmacol (in press)
Colpaert FC, Janssen PAJ (1983a) A characterization of LSD-antagonist effects of pirenperone in the rat. Neuropharmacology 22:1001–1005
Colpaert FC, Janssen PAJ (1983b) The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist. Neuropharmacology 22:993–1000
Colpaert FC, Janssen PAJ (1984) Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization. J Pharmacol Exp Ther (in press)
Colpaert FC, Niemegeers CJE, Janssen PAJ (1976) Theoretical and methodological considerations on drug discrimination learning. Psychopharmacologia 46:169–177
Colpaert FC, Niemegeers CJE, Janssen PAJ (1979) In vivo evidence of partial agonist activity exerted by purported 5-hydroxytryptamine antagonists. Eur J Pharmacol 58:505–509
Colpaert FC, Niemegeers CJE, Janssen PAJ (1982) A drug discrimination analysis of lysergic acid diethylamide: in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD-antagonist. J Pharmacol Exp Ther 221:206–214
Commissaris RL, Rech RH (1982) Interactions of metergoline with diazepam, quipazine, and hallucinogenic drugs on a conflict behavior in the rat. Psychopharmacology 76:282–285
Cook L, Davidson AB (1973) Effects of behaviorally active drugs in a conflict-punishment procedure in rats. In: Garattini S (ed) The benzodiazepines, Raven Press New York, pp 327–345
Cook L, Sepinwall J (1975) Behavioral analysis of the effects and mechanism of action of benzodiazepines. In: Costa E, Greengard P (eds) Mechanism of action of benzodiazepines, Raven Press New York, pp 1–28
Corne SJ, Pickering RW, Warner BT (1963) A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br J Pharmacol 20:106–120
Crawley JN (1981) Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 15:695–699
Crawley JN, Davis LG (1982) Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains. Brain Res Bull 8:609–612
Crawley JN, Goodwin FK (1980) Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13:167–170
De Shon HJ, Rinkel M, Solomon HC (1952) Mental changes experimentally produced by LSD. Psychiatr Q 26:33–53
Dooley DJ, Quock RM (1976) Tryptamine and 5-hydroxytryptamine-induced hypothermia in mice. J Pharm Pharmacol 28:775–776
Finney DJ (1971) Statistical methods in biological assay. 2nd ed, Griffin Press London
Freedman DX (1968) On the use and abuse of LSD. Arch Gen Psychiatry 18:330–347
Freedman DX (1969) The psychopharmacology of hallucinogenic agents. Annu Rev Med 20:408–418
Geller I, Blum K (1970) The effects of 5-HTP on parachlorophenylalanine (p-CPA) attenuation of “conflict” behavior. Eur J Pharmacol 9:319–324
Geller I, Seifter J (1960) The effects of meprobamate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1:482–492
Geller I, Hartmann RJ, Croy DJ (1974) Attenuation of conflict behavior with cinanserin, a serotonin antagonist: reversal of the effect with 5-hydroxytryptophan and α-methyltryptamine. Res Commun Chem Pathol Pharmacol 7:165–174
Glennon RA, Rosecrans JA, Young R (1982) The use of the drug discrimination paradigm for studying hallucinogenic agents. A review. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology, Elsevier Biomedical Press Amsterdam, pp 69–98
Graeff FG (1974) Tryptamine antagonists and punished behavior. J Pharmacol Exp Ther 189:344–350
Graeff FG, Schoenfeld RI (1970) Tryptaminergic mechanisms in punished and nonpunished behavior. J Pharmacol Exp Ther 173:277–283
Henning M, Rubenson A (1971) Effects of 5-hydroxytryptophan on arterial blood pressure, body temperature and tissue monoamines in the rat. Acta Pharmacol Toxicol 29:145–154
Herling S, Woods JH (1981) Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions. Life Sci 28:1571–1584
Holmberg G, Gershon S (1961) Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacologia 2:93–106
Holtzman SG (1982a) Stimulus properties of opioids with mixed agonist and antagonist activity. Fed Proc 41:2328–2332
Holtzman SG (1982b) Discriminative stimulus properties of opioids in the rat and squirrel monkey. In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology, Elsevier Biomedical Press Amsterdam, pp 17–36
Holtzman SG, Shannon HE, Schaefer GJ (1977) Discriminative properties of nacrotic antagonists. In: Lal H (ed) Discriminative stimulus properties of drugs, Plenum Press New York, pp 47–72
Howard JL, Rahrbach KW, Pollard GT (1982) Cumulative dose-effect curves in a conflict test with incremental shock. Psychopharmacology 78:195–196
Isbell H (1959) Comparison of the reactions induced by psilocybin and LSD-25 in man. Psychopharmacologia 1:29–38
Janssen PAJ (1982) The pharmacology of specific, pure and potent serotonin 5 HT2 or S2 antagonists. In: Yoshida H, Hagihara Y, Ebashi S (eds) Advances in pharmacology and therapeutics II, vol 4, Biochemical and immunological pharmacology, Pergamon Press New York, pp 21–33
Kety SS (1967) The hypothetical relationships between amines and mental illness; a critical synthesis. In: Hirnwich HE, Kety SS, Smythies JR (eds) Amines and schizophrenia, Pergamon Press New York, pp 271–277
Lessin AW, Parkes MW (1957a) The hypothermic and sedative action of reserpine in the mouse. J Pharm Pharmacol 9:657–662
Lessin AW, Parkes MW (1957b) The relation between sedation and body temperature in the mouse. Br J Pharmacol 12:245–250
Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981) Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sci 28:1015–1022
Litchifield JT, Wilcoxon F (1949) A simplified method for evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99–113
Matthews WD, Smith CD (1980) Pharmacological profile of a model for central serotonin receptor activation. Life Sci 26:1397–1403
McCoun TJ, Vogel RA, Breese GR (1983) An efficient chronic conflict paradigm: lick suppression by incremental footschock. Pharmacol Biochem Behav 18:227–279
Morato de Carvalho S, De Aguiar JC, Graeff FG (1981) Effect of minor tranquillizers, tryptamine antagonists and amphetamine on behavior punished by brain stimulation. Pharmacol Biochem Behav 15:351–356
Niemegeers CJE, Colpaert FC, Leysen JE, Awouters F, Janssen PAJ (1983) Mescaline-induced head-twitches in the rat: an in vivo method to evaluate serotonin S2 antagonists. Drug Dev Res 3:123–135
Nishikawa T, Tanaka M, Tsuda A, Kohno Y, Nagasaki N (1983) Serotonergic-catecholaminergic interactions and foot shock-induced jumping behavior in rats. Eur J Pharmacol 94:53–58
Petersen EN, Lassen JB (1981) A water lick conflict paradigm using drug experienced rats. Psychopharmacology 75:236–239
Salvatore S, Hyde RW (1956) Progression of effects of lysergic acid diethylamide (LSD). Arch Neurol Psychiatry 76:50–59
Sandison RA, Spencer AM, Whitelaw JDA (1954) The therapeutic value of lysergic acid diethylamide in mental illness. J Ment Sci 100:491–507
Shearman GT, Herz A (1982) Genera;ization and antagonism studies with rats trained to discriminate an effect of the proposed sigma receptor agonist N-allylnormetazocine (SKF 10,047). In: Colpaert FC, Slangen JL (eds) Drug discrimination: applications in CNS pharmacology, Elsevier Biomedical Press Amsterdam, pp 37–48
Siegel S (1956) Nonparametric statistics for the behavioral sciences. McGraw Hill Book Co New York
Stein L, Wise CD, Berger BD (1973) Antianxiety action of benzodiazepines: decrease in activity in serotonin neurons in the punishment system. In: Garattini S (ed) The benzodiazepines, Raven Press New York, pp 299–326
Thiébot M-H, Hamon M, Soubrié P (1983) The involvement of nigral serotonin innervation in the control of punishment-induced behavioral inhibition in rats. Pharmacol Biochem Behav 19:225–229
Thiébot M-H, Soubrié P, Hamon M, Simon P (1984) Evidence against the involvement of serotonergic neurons in the antipunishment activity of diazepam in the rat. Psychopharmacology 82:355–359
Tye NC, Everitt BJ, Iversen SD (1977) 5-Hydroxytryptamine and punishment. Nature 268:741–743
Van Nueten JM, Janssen PAJ, Van Beek J, Xhonneux R, Verbeuren TJ, Vanhoutte PM (1981) Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther 218:217–230
Vogel RA, Frye GD, Wilson JH, Kuhn CM, Koephe KM, Mailman RB, Mueller RA, Breese GR (1980) Attenuation of the effects of punishment by ethanol: comparisons with chlordiazepoxide. Psychopharmacology 71:123–129
Vogel RJ, Beer B, Clody DE (1971) A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21:1–7
Weissman A (1978) Generalization of the discriminative stimulus properties of β 9-tetrahydrocannabinol to cannabinoids with therapeutic potential. In: Colpaert FC, Rosecrans JA (eds) Stimulus properties of drugs: ten years of progress, Elsevier Biomedical Press Amsterdam, pp 99–124
White FJ, Appel JB (1982a) Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions. Science 216:535–536
White FJ, Appel JB (1982b) Training dose as a factor in LSD-saline discrimination. Psychopharmacology 76:20–25
Whitmayer DI, Masco D, Carrer HF (1983) An electronic open field. Physiol Behav 30:635–637
Winter JC (1972) Comparison of chlordiazepoxide, methysergide and cinanserin as modifiers of punished behavior and as antagonists of N,N-dimethyltryptamine. Arch Int Pharmacodyn Ther 197:137–159
Wise CD, Berger BD, Stein L (1972) Benzodiazepines: anxiety-reducing activity by reduction of serotonin turnover in the brain. Science 177:180–183
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Colpaert, F.C., Meert, T.F., Niemegeers, C.J.E. et al. Behavioral and 5-HT antagonist effects of ritanserin: A pure and selective antagonist of LSD discrimination in rat. Psychopharmacology 86, 45–54 (1985). https://doi.org/10.1007/BF00431683
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00431683